Can Helicobacter pylori infection and intestinal dysbiosis contribute to thyroid autoimmunity?

Helicobacter pylori–related gastritis and altered gut microbial ecology provide a biologically credible mucosal–immune context for thyroid autoimmunity, but the full causal chain has not been established in humans.

Clinical and inflammatory evidence

• H. pylori is well supported as a cause of local gastric immune activation: infected gastric biopsies show increased IL-8 and granulocyte infiltration. BabA/babA2-positive strains, which adhere more densely to epithelium, are associated with greater IL-8 expression, IL-33 mRNA, and active gastritis.
• In a prospective adult study, fecal calprotectin was higher with H. pylori, correlated with histologic gastritis activity, and declined after eradication. This supports infection-associated inflammatory activity, although calprotectin is not specific to H. pylori.
• Dysbiosis has weaker, associative support. In older adults, reduced short-chain-fatty-acid–producing genera accompanied higher calprotectin, IL-17C, and CCL19; however, an adult IBD study found no correlation between dysbiosis indices and calprotectin or fecal IgA.

Mechanistic relevance to thyroid autoimmunity

• Barrier and microbial-product pathways are coherent: epithelial disruption may permit lipopolysaccharide and other antigens to activate pattern-recognition/Toll-like receptor signaling, antigen presentation, and systemic inflammation.
• Autoimmune thyroid disease is associated with increased Th17-related IL-17/IL-21 activity and reduced Treg/regulatory-cytokine activity. Reduced SCFA-producing taxa could theoretically impair Treg induction while favoring Th17 polarization.
• Hashimoto cohorts have reported higher zonulin and occasional associations with anti-TPO, but zonulin is an imperfect permeability marker. Molecular mimicry involving thyroid peroxidase, thyroglobulin, or TSH-receptor epitopes remains a plausible hypothesis, not a demonstrated pathogenic mechanism in humans.

Bottom line

• H. pylori can sustain gastric mucosal inflammation, and dysbiosis may contribute to intestinal immune activation. These processes could amplify inflammatory, barrier-related, and cross-reactive pathways relevant to thyroid autoimmunity, but existing associations do not show that they initiate or cause thyroid disease.